Linfoma de burkitt como adenopatía axilar en un paciente inmunosuprimido

• Hélio Martins ^[1] ; David Paiva ^[1] ; Margarida Cerqueira ^[1] ; Jorge Cotter ^[1]
  1. [1] Department of Internal Medicine. Hospital da Senhora da Oliveira – Guimarães, Braga, Portugal
• Localización: Galicia Clínica, ISSN 0304-4866, ISSN-e 1989-3922, Vol. 82, Nº. 2 (Abril-Mayo-Junio), 2021, págs. 99-100
• Idioma: español
• Títulos paralelos:
  • Burkitt lymphoma as an axillary adenopathy in an immunosuppressed patient
• Enlaces
  • Texto completo
• Resumen

  • Burkitt lymphoma is derived from germinal or post-germinal center B cells and is a highly aggressive B cell non-Hodgkin lymphoma that represents <1 percent of adult non-Hodgkin lymphomas. The authors describe the case of a 63 years old Caucasian male, with history of human immunodeficiency virus infection, latent syphilis and varicella zoster infection on the left limb (L3 dermatome) who came to the emergency department with a palpable left axillary mass with three weeks evolution accompanied with vesicles 48 hours after. He reported a history of anorexia and weight loss on the past 3 months.

    Complete blood count was within normal range but was observed a fivefold elevation of lactate dehydrogenase and a CD4 count <200cells/microL. The histology of the adenopathic axillar conglomerate made the diagnosis of Burkitt lymphoma but, besides all efforts, the patient ended to die before starting a regimen of chemotherapy